key: cord-0955250-yvl8rkak
authors: Sloan, Brett
title: This Month in JAAD Case Reports: March 2021
date: 2021-01-15
journal: J Am Acad Dermatol
DOI: 10.1016/j.jaad.2021.01.003
sha: 59fe7f9f0375a11a5d6ef6449a5b3f04d9e83f23
doc_id: 955250
cord_uid: yvl8rkak

nan

This Month in JAAD Case Reports:

March 2021

Brett Sloan, MD Farmington, Connecticut C oronavirus disease 19 (COVID-19) has rarely been associated with immune thrombocytopenic purpura (ITP). Of the few cases reported, [90% had at least 1 symptom of COVID-19. 1 In the November edition of JAAD Case Reports, Lobos et al 2 reported a 22 year old healthy active male who presented via a tele-dermatology consultation with an asymptomatic petechial eruption on his lower extremities after vigorous exercise. His review of symptoms was negative for COVID-19 symptoms yet he had reported gingival bleeding and a buccal hematoma after a dental procedure 1 day prior. A full laboratory workup revealed a platelet count of 1000/L and an oropharyngeal swab positive for SARS-Cov-2. Fortunately, he remained asymptomatic of COVID-19 symptoms and his platelet count and petechial eruption improved after receiving intravenous immunoglobulin and eltrombopag.

Numerous cutaneous eruptions have been associated with COVID-19. Given the well-known association of viruses with ITP, it is not surprising that SARS-Cov-2 is added to this list. The case presented by Lobos et al 2 is a great example of the utility of tele-dermatology during this pandemic and a stark reminder to have a low threshold on thoroughly investigating any petechial eruption regardless of symptomology.

Immune thrombocytopenia secondary to COVID-19: a systematic review

Immune thrombocytopenic purpura associated with coronavirus disease 2019 infection in an asymptomatic young healthy patient

None to report.